BioStem Technologies Capital Expenditures (CapEx) Growth & History (BSEM)
BioStem Technologies's capital expenditures (capex) was $0 for fiscal 2025.
View full BioStem Technologies company overviewBioStem Technologies annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | −$210,330 | — |
| 2023 | 2023-12-31 | $210,330 | −$259,154 | −55.20% |
| 2022 | 2022-12-31 | $469,484 | $426,636 | +995.70% |
| 2021 | 2021-12-31 | $42,848 | — | — |
BioStem Technologies quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $57,925 | −$439,225 | −88.35% |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q3 2025 | 2025-09-30 | $2.4M | — | — |
| Q2 2025 | 2025-06-30 | $497,150 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q4 2024 | 2024-12-31 | $131,331 | — | — |
BioStem Technologies capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, BioStem Technologies's capital expenditures (capex) decreased from $42,848 to $0, a change of −$42,848. The latest reported quarter, Q2 2026, shows $57,925.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioStem Technologies source filings ↗